Intermolecular announced on the 17th that it has signed a collaborative development program (CDP) and royalty-bearing IP licensing agreement with Taiwan Epistar, in order to jointly improve power of LED devices and reduce production costs of the latter.

The engineers from Epistar and Intermolecular will take the advantages of Intermolecular's highly productive combination (HPC) technology platform based on this agreement to vigorously promote the development and manufacturing of advanced new materials and processing technology for LED products.

"After a rigorous review of Intermolecular’s capabilities through an initial collaboration engagement, we have seen how their combinatorial approach to materials innovation and device integration can augment Epistar's leadership in LED technology," said M. J. Jou, president of Epistar. "Collaboration with our industry partners has been critical to our world-leading R&D and manufacturing strategy. We are confident that leveraging Intermolecular's team and technology platform will further increase our competitive advantage."

As the competition in commercial LED market is fierce, the premise behind the success of new technology is to increase the light output and reduce costs simultaneously. Compared with the traditional LED lab, the cooperation between technicians from the two companies makes the R&D experimentation to be performed at speeds up to 100 times faster than traditional methods.